Study Objectives-To assess the value of death certification for the epidemiological study of dementia, the frequency with which the condition was recorded on death certificates of patients diagnosed with some form of dementia before the age of 65 years was studied. A further objective was to identify variables associated with failure to record dementia on the certificate. Design Two large national studies4 5 have examined death certificate practices with regard to dementia amongst all deaths. In an Australian national study of regional differences in mortality from dementia that examined the underlying cause ofdeath over a seven year period, Jorm et al4 noted wide regional variations in the frequency with which dementia was reported and suggested that these were largely the result ofvariations in the practice of individual doctors. In a US national study5 ofdeaths in which senile and presenile dementia were given as the underlying causes, there was considerable underreporting of the frequency of these conditions compared with their prevalence, as estimated from epidemiological studies.
Death certification, based on the certified underlying cause of death, has been used to map the geographical distribution of diseases. Cerebrovascular disease and dementia have been studied in this way.' Martyn and Pippard2 suggested that these data were not useful in exploring geographical variations in the frequency of dementia because of the low rate of the reporting of this condition in clinical cases of dementia. This has also been found in a series ofwell established cases of Alzheimer's disease, where dementia or Alzheimer's disease was given as the underlying cause of death in only 63% ofcases3; the mean age at death in this study was 80 years.
Two large national studies4 5 have examined death certificate practices with regard to dementia amongst all deaths. In an Australian national study of regional differences in mortality from dementia that examined the underlying cause ofdeath over a seven year period, Jorm et al4 noted wide regional variations in the frequency with which dementia was reported and suggested that these were largely the result ofvariations in the practice of individual doctors. In a US national study5 ofdeaths in which senile and presenile dementia were given as the underlying causes, there was considerable underreporting of the frequency of these conditions compared with their prevalence, as estimated from epidemiological studies.
As an extension of a study that examined point prevalence, incidence, and survival in cases of presenile dementia diagnosed before the age of 65 years in the Northern Regional Health Authority,6 we report here the frequency of dementia as the underlying cause of death and compare it with the frequency ofdementia as a contributory cause and with cerebrovascular disease and other cerebral diseases. Some other causes of death are also noted. We also attempt to identify variables associated with absence of dementia on the certificate, examine changes over time and differences between health districts, and study the relationship between clinically diagnosed types of dementia and causes of death given on the different parts of the death certificate. Finally, the use of death certification data for epidemiological research is discussed. Duration of disease (onset of symptoms to death) In patients in whom the duration of disease was less than five years, dementia was reported less often (47%) than for those with a longer disease period (73%); this difference was highly significant (X2=15 6, DF=2, p<001). This finding was not explained by clinical diagnosis.
Methods
Place of death There was no significant difference in the recording of dementia or Alzheimer's disease in hospital deaths compared with those in the community. A total of 171 cases (66%) died in hospital, 53 (21%) at home and 33 (13%) in a residential or nursing home. The percentage of deaths that occurred in nursing or residential homes increased during 1986-92 (6% in 1986-7, 9% in 1988-9, and 16% in 1990 and later).
Discussion
The relationship between the information given on death certificates and the diagnosis during life can be regarded from two points of view. The death certificate may be used to confirm or otherwise the correctness of the clinical diagnosis, particularly when a necropsy has been performed; however, to establish the cause of dementia this would have to include histopathological examination of the brain. In this sample necropsy was undertaken in only 10% and in none was histology available.
Alternatively, death certificates may be used as a source of information about the presence of a particular disease or condition in a population; Clinical diagnosis PDAT PVD Other Total A 9 ANewens, D P Forster, D W K Kay for instance to study regional differences in dementia.'2 In addition, a reference to dementia on the certificate would suggest that the patient had been chronically disabled and dependent.
VALIDITY OF DIAGNOSIS
The general validity of the method of establishing the clinical diagnosis from case note review is supported by the calculation that in an unselected population of similar size and matched for sex and age at death, only one case of a dementing illness recorded as the underlying cause on the death certificate would be expected'0 whereas in our group 113 (42%) of these cases were observed. It would be wrong to assume that the remaining cases were not demented since 22% died from the effects of cerebral or cerebrovascular disease, and in a further 14% dementia or cerebral disease was mentioned on the certificate though not as the underlying cause of death. Some 80% of all patients and 83% of PDAT patients had some form of cerebral disease referred to on the certificate, which is a reasonable validation of clinical diagnosis.
There was a potential conflict between the algorithm diagnosis and the recorded causes of death in some cases. For example, of the 173 cases of PDAT cerebrovascular dementia was referred to in 18 (10%) cases and in a further 19 (1 1 %) cases a cerebral disease other than Alzheimer's disease was recorded; cerebrovascular disease (1 1) Parkinson's disease (four), cerebral atrophy (two), epilepsy (one) cerebellar ataxia (one), (columns 3 (table III) .
Except for the ad hoc study referring to the years 1985-6,1' the frequency with which dementia is noted at any point on the death certificate is not available in England and Wales. In the US, in a national study, Chandra et al '4 found that age adjusted rates of dementia (senile and presenile) were about five times higher for death with any mention of these conditions than for death from these conditions when listed as the underlying cause.
In this study Alzheimer's disease or dementia was recorded was the immediate cause of death in 12% of PDAT cases (table III) . This is much higher than the 1% reported as the primary (sic) cause of death in a study of older patients with Alzheimer's disease,3 and may be related to the better general health of younger patients, though the meaning of the term primary in not quite clear.
As in clinical studies of older patients,2 3 15 16 the commonest immediate cause of death was bronchopneumonia.
In this study Alzheimer's disease or dementia was the underlying cause of death in 44% of cases compared with 22% in the study of older patients by Martyn and Pippard.' However, the rules for determining the underlying cause of death changed during the course of the latter study , which may account for some of this difference. Unlike this earlier study, reporting of dementia was not related to place of death (hospital or community). Dementia or Alzheimer's disease was the commonest underlying cause of death in PDAT whereas in other clinical types of dementia death was relatively more often caused by cerebrovascular disease, other cerebral disease, or systemic disease. In just over half of cases in whom the underlying cause of death was a noncerebral cause, dementia or Alzheimer's disease was mentioned on the certificate.
In this sample, dementia or Alzheimer's disease was mentioned on any part on the death certificate in 65%, about as often as reported by Martyn and Pippard2 (57%), but in PDAT patients the rate was higher and similar to the 70% reported by Burns et 
